MedKoo Cat#: 127927 | Name: TM5007
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TM5007 is a poent and orally active inhibitor of plasminogen activator inhibitor-1 (PAI-1) with an IC50 of 29 μM. TM5007 enhance fibrinolysis activity and inhibits coagulation. TM5007 also prevents the fibrotic process initiated by bleomycin in mouse lung.

Chemical Structure

TM5007
TM5007
CAS#342595-05-5

Theoretical Analysis

MedKoo Cat#: 127927

Name: TM5007

CAS#: 342595-05-5

Chemical Formula: C24H20N2O6S4

Exact Mass: 560.0204

Molecular Weight: 560.67

Elemental Analysis: C, 51.41; H, 3.60; N, 5.00; O, 17.12; S, 22.87

Price and Availability

Size Price Availability Quantity
25mg USD 550.00 2 Weeks
100mg USD 1,650.00 2 Weeks
1g USD 4,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TM5007; TM-5007; TM 5007
IUPAC/Chemical Name
5',5'''-(adipoylbis(azanediyl))bis(([2,3'-bithiophene]-4'-carboxylic acid))
InChi Key
USLUSWIVVBUXLU-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H20N2O6S4/c27-17(25-21-19(23(29)30)13(11-35-21)15-5-3-9-33-15)7-1-2-8-18(28)26-22-20(24(31)32)14(12-36-22)16-6-4-10-34-16/h3-6,9-12H,1-2,7-8H2,(H,25,27)(H,26,28)(H,29,30)(H,31,32)
SMILES Code
O=C(NC1=C(C(O)=O)C(C2=CC=CS2)=CS1)CCCCC(NC3=C(C(O)=O)C(C4=CC=CS4)=CS3)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 560.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Yamaoka N, Kawano Y, Izuhara Y, Miyata T, Meguro K. Structure-activity relationships of new 2-acylamino-3-thiophenecarboxylic acid dimers as plasminogen activator inhibitor-1 inhibitors. Chem Pharm Bull (Tokyo). 2010 May;58(5):615-9. doi: 10.1248/cpb.58.615. PMID: 20460785. 2: Izuhara Y, Takahashi S, Nangaku M, Takizawa S, Ishida H, Kurokawa K, van Ypersele de Strihou C, Hirayama N, Miyata T. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):672-7. doi: 10.1161/ATVBAHA.107.157479. Epub 2008 Jan 31. PMID: 18239154. 3: Izuhara Y, Yamaoka N, Kodama H, Dan T, Takizawa S, Hirayama N, Meguro K, van Ypersele de Strihou C, Miyata T. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates. J Cereb Blood Flow Metab. 2010 May;30(5):904-12. doi: 10.1038/jcbfm.2009.272. Epub 2010 Jan 20. PMID: 20087372; PMCID: PMC2949193.